Eradication of persistent methicillin-resistant Staphylococcus aureus infection in cystic fibrosis
Rebecca Dezube(Johns Hopkins University), Elliott C. Dasenbrook(Cleveland Clinic), Mary F. Rykiel(Johns Hopkins University), Mark T. Jennings(Johns Hopkins University), Michael Boyle(McMaster University), James F. Chmiel(Riley Hospital for Children), Marie Diener‐West(Johns Hopkins University)
Cited by 42
Related Papers
Update on Key Emerging Challenges in Cystic Fibrosis
|Medical Principles and Practice|2014|3.7k
Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del<i>CFTR</i>
|New England Journal of Medicine|2015|1.6k
Multiattribute and Single-Attribute Utility Functions for the Health Utilities Index Mark 3 System
|Medical Care|2002|1.3k
Soluble Human Complement Receptor Type 1: In Vivo Inhibitor of Complement Suppressing Post-Ischemic Myocardial Inflammation and Necrosis
|Science|1990|979
Inflammatory subtypes in asthma: Assessment and identification using induced sputum
|Respirology|2006|939